One- year efficacy and safety of adapalene gel 0.1% gel in Japanese patients with acne vulgaris

Skin Research

Volumn 6, Issue 5, 2007, Pages 504-512

  Kawashima, Makoto ^a   Harada, Shotaro ^b   Andres, Philippe ^c   Miyachi, Yoshiki ^d  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

^c Galderma R and D   (France)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Acne vulgaris; Adapalene; Long term; Topical retinoid

Indexed keywords

ADAPALENE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; ERYTHEMA; FEMALE; GEL; HUMAN; INFLAMMATION; JAPANESE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT SATISFACTION; PRURITUS; SCHOOL CHILD; SKIN DISCOMFORT; SKIN EXFOLIATION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 37349121169     PISSN: 13471813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Thiboutot D : Regulation of Human Sebaceous Glands. J Invest Dermatol 2004 ; 123 : 1-12
2. Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, Dreno B : Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004 ; 14 (1) : 4-12
3. Leyden JJ : A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003 ; 49 (3 suppl) : S200-S210
4. Thiboutot D : New treatments and therapeutic strategies for acne. Arch Family Med 2000 ; 9 : 179-187
5. Gollnick H, Cunliffe W, Berson D, et al : Management of acne. A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003 ; 49 (1 suppl) : S1-S37
6. Wolf JE : Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherence. SKINmed 2004 ; 3 : 23-26
7. Cunliffe WJ, Holland DB, Clark SM, Stables, GI : Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000 ; 142 : 1084-1091
8. Haider A, Shaw JC : Treatment of acne vulgaris. JAMA 2004 ; 292 : 726-735
9. Gollnick H, Schramm M : Topical drug treatment in acne. Dermatology 1998 ; 196 : 119-125
10. Brogden RN, Goa KL : Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs. 1997 ; 53 : 511-519
11. Michel S, Jomard A, Demarchez M : Pharmacology of adapalene. Br J Dermatol 1998 ; 139 (suppl 52) : 3-7
12. Vega B, Jomard A, Michel S : Regulation of human monocyte toll-like receptor 2 (TLR2) expression by adapalene. J Eur Acad Dermatol Venereol 2002 ; 16 (suppl 1) : 123-124 [Abstract]
13. Shroot B, Michel S : Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997 ; 36 : S96-103
14. Cunliffe WJ, Poncet M, Loesche C, Verschoore M : A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol 1998 ; 139 : 48-56
15. Waugh J, Noble S, Scott LJ : Adapalene : a review of its use in the treatment of acne vulgaris. Drugs. 2004 ; 64 : 1465-1478
16. Thielitz A, Sidou F, Gollnick H : Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. JEADV, 2007 ; 21 : 741-753
17. Kawashima M, et al : Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study. Submitted.
18. Kawashima M, et al : Adapalene Gel 0.1% - a topical retinoid-like molecule - for the treatment of Japanese patients with acne vulgaris : a multicenter, randomized, investigator-blinded, dose-ranging study. Submitted.
19. Hayashi N, Kawashima M, Watanabe S, et al : An Epidemiological Study of Acne Vulgaris in Japan by Questionnaire. Jpn J Dermatol 2001 ; 111 : 1347-1355
20. Zhang J, Li L, Tu Y, Zhengjie : A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat. In press.
21. Cassano N, Amoruso A, Alessandrini G, et al : Treatment of inflammatory acne with a combination therapy with lymecycline and adapalene followed by maintenance treatment with adapalene. Eur J Inflam. 2004 ; 2 (1) : 45-52
22. Thiboutot D, Shalita A, Yamauchi PS. et al : Adapalene gel 0.1% as maintenance therapy for acne vulgaris: A randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006 May ; 142 (5) : 597-602
23. Leyden J, Thiboutot DM, Shalita AR, et al : Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris : a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 2006 May ; 142 (5) : 605-612
24. Alirezai M, George SA, Coutts I, et al : Daily Treatment with Adapalene Gel 0.1% Maintains Initial Improvement of Acne Vulgaris Previously Treated with Oral Lymecycline. Eur J Dermatol. In press.
25. Thielitz A, Helmdach M, Ropke EM, Gollnick H : Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents. Br. J. Dermatol 2001 ; 145 : 19-27
26. Berson DS : Topical retinoids in primary care practice. Medscape. published online : July 2003. htto://www.medscape.com/viewDrogram/2575_pnt.